alectinib

You have access
Evaluation of Lung Toxicity Related to the Treatment With Alectinib Using a Pharmacovigilance Database
JUNYA SATO, MAYAKO UCHIDA, HARUKA WAKABAYASHI and TADASHI SHIMIZU

Anticancer Research June 2022, 42 (6) 3109-3116; DOI: https://doi.org/10.21873/anticanres.15799
You have access
ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
KATHRIN FLESCHUTZ, LISA WALTER, RUMO LEISTNER and LUCIE HEINZERLING

Anticancer Research September 2020, 40 (9) 4937-4946; DOI: https://doi.org/10.21873/anticanres.14497
You have access
Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study
SHINICHIRO OKAUCHI, TAKESHI NUMATA, TAKESHI NAWA, HIDEO ICHIMURA, TAKEFUMI SAITO, KENJI HAYASHIHARA, HIDEYASU YAMADA, HIROAKI SATOH, TAKESHI ENDO, YOSHIHISA INAGE, TAKAYUKI KABURAGI, MORIYUKI KIYOSHIMA, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUHITO SAITO, MASAHARU INAGAKI, NOBUYUKI HIZAWA, YUKIO SATO, TOSHIHIRO SHIOZAWA, IKUO SEKINE, HIROICHI ISHIKAWA, KOICHI KURIHIMA, MITSUAKI SAKAI, KOICHI KAMIYAMA, MASAKI KIMURA, NORIHIRO KIKUCHI, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAHIDE KODAMA, KUNIHIKO MIYAZAKI, TAKAAKI YAMASHITA, SHIGEN HAYASHI, YASUNORI FUNAYAMA and AKIHIRO NOMURA

Anticancer Research February 2020, 40 (2) 957-964; DOI: https://doi.org/10.21873/anticanres.14029
You have access
Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B–ALK Fusion Oncokinase
NAOKI SHIMIZU, YUSAKU AKASHI, TOMOMI FUJII, HIROYUKI SHIONO, KATSUNARI YANE, TADASHI KITAHARA, YOSHIO OHTA, KENNICHI KAKUDO and TOMOKO WAKASA

Anticancer Research January 2019, 39 (1) 413-420; DOI: https://doi.org/10.21873/anticanres.13127
You have access
Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
RALPH L. MILLETT, JACOB M. ELKON and IMAD A. TABBARA

Anticancer Research September 2018, 38 (9) 4969-4975; DOI: https://doi.org/10.21873/anticanres.12815
You have access
Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure
YUKO OYA, TATSUYA YOSHIDA, HIROAKI KURODA, JUNICHI SHIMIZU, YOSHITSUGU HORIO, YUKINORI SAKAO, TOYOAKI HIDA and YASUSHI YATABE

Anticancer Research November 2017, 37 (11) 6477-6480;

Main menu

User menu

Search

alectinib